Tag Archives: Diabetes Moonshot

An Inside Look at the ADA's Launch of the Obesity Association

American Diabetes Association Launches Obesity Association



In this episode of StartUp Health NOW, Chuck Henderson, the CEO of the American Diabetes Association (ADA) and a member of StartUp Health’s Health Moonshot Impact Board, took time out of his busy schedule at the recent ADA Scientific Sessions – the ADA’s annual global gathering of more than 11,000 people working on foundational products and bleeding-edge ideas related to both Type 1 and Type 2 diabetes – to chat with us about innovation, collaboration, and the ADA’s latest initiatives.

  • Launch of the Obesity Association: The ADA has announced the formation of the Obesity Association, which will now be a division within the ADA, focusing heavily on integrating obesity care into diabetes standards.
  • Cutting-Edge Research: The ADA is doubling down on its efforts to combat obesity by incorporating it more thoroughly into their standards of care, considered a critical resource in diabetes management.
  • Health Equity: A significant focus is on health equity, ensuring that all programs are accessible and beneficial to underserved communities, including rural areas.
  • Community Outreach: The ADA has initiated programs like mobile clinics in rural Alabama to address diabetic retinopathy, demonstrating their commitment to reaching underserved populations.
  • Innovation and Competition: The ADA values innovation and competition, fostering early-stage research and encouraging disruptive ideas to push forward diabetes care and treatment.
  • Collaboration with StartUp Health: Chuck Henderson expressed his appreciation for his involvement with StartUp Health. He highlights StartUp Health’s role in connecting communities and emphasized the importance of our ecosystem in addressing chronic illnesses through innovative solutions like the Type 1 Diabetes Moonshot.

 


 

Innovating in Alzheimer’s disease? Learn how you can join our Alzheimer’s Moonshot.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

FundersBecome a Health Moonshot Champion


DCB’s Fresh Take on Empowering Diabetes Innovation

How This Swiss Non-Profit Empowers Diabetes Innovation



Transforming diabetes management with DCB: On this week’s StartUp Health NOW, we chat with Greta Ehlers from Diabetes Center Berne (DCB) at the 2024 American Diabetes Association Scientific Sessions.

DCB’s mission? Revolutionize diabetes management with a unique global innovation challenge that attracts 100+ innovative startups.

In this episode, we explore:

  • Cutting-edge trends: Discover how AI and non-invasive monitoring are simplifying daily life for people with diabetes.
  • A supportive launchpad: Learn about DCB’s program, featuring an application process, expert evaluation, and an in-person boot camp in Switzerland for finalists.
  • Building a community: This intensive boot camp fosters collaboration, one-on-one coaching, and lasting connections between startups.
  • Making a global impact: Funded by a private benefactor, DCB offers startups the resources and connections they need to transform diabetes management worldwide.
  • Making it personal: Ehlers, like many DCB team members, has a personal connection to diabetes, enhancing the commitment and understanding of the challenges faced by those living with diabetes.

Listen in to see how DCB is bringing the future of diabetes care closer, one innovative idea at a time!



Innovating in Alzheimer’s disease?
 Learn how you can join our Alzheimer’s Moonshot.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

FundersBecome a Health Moonshot Champion


Mission Aligned: Helmsley Charitable Trust and StartUp Health on T1D Moonshot



Welcome back to StartUp Health NOW, the podcast where we hear directly from the entrepreneurs and innovators who are transforming health.

Typically on this show we talk to founders of startups. We’re all about understanding what’s new and next in health, and that often means talking to the people who are in the early days of creating a product or business. Most early-stage startups – healthcare or otherwise – have one thing in common. They need money. It takes a long time to get a healthcare business profitable, and so founders need outside funds to get an idea off the ground, complete their research, or scale up.

That brings us to this week’s guest, David Panzirer, Trustee at the Helmsley Charitable Trust. To put it in simple startup terms, David is a funder. The Helmsley Charitable Trust is an $8 billion dollar philanthropy renowned for its work funding healthcare research and innovative programs.

Of course David’s a lot more than a funder. He’s a father, for one thing, a fact that’s driven his work more than anything else. David’s also a firebrand and an instigator in an industry that often needs a little push in the right direction.

The reason for our interview, which took place at a recent health tech event, is that the Helmsley Charitable Trust has been the anchor partner for StartUp Health’s Type 1 Diabetes Moonshot, and David has been instrumental in getting that effort off the ground. He’s been part of our T1D Impact Board and has met with founders on multiple occasions to give them invaluable feedback and advice.

In this episode, we talk about the wild west of conversational AI, promising new T1D therapeutics, rural medicine, and why Helmsley has positioned itself as a high risk/high reward funder.

Let’s get into it.



Passionate about Type 1 diabetes? Contact us to learn how you can join our T1D Moonshot.
Innovating in Alzheimer’s disease? Contact us to learn how you can join our Alzheimer’s Moonshot.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

FundersBecome a Health Moonshot Champion

 

 


Why the CEO of the American Diabetes Association (ADA) Joined StartUp Health’s Health Moonshot Impact Board



Since 2020, Charles “Chuck” Henderson has led the American Diabetes Association (ADA) as CEO. In 2023, he joined StartUp Health’s Health Moonshot Impact Board, a unique, multi-disciplinary group of stakeholders passionate about advancing health innovation. On the Health Moonshot Impact Board, Henderson joins top thought leaders like Dr. Toby Cosgrove (former CEO, Cleveland Clinic) and Sue Siegel (former CEO, GE Ventures).

In this StartUp Health NOW episode, StartUp Health’s Logan Plaster sat down with Henderson to learn about his priorities in leading the ADA and why it was important to him to join StartUp Health’s moonshot community.


FundersBecome a Health Moonshot Champion
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Looking to break down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.
Passionate about Type 1 diabetes? If you’re an entrepreneur or investor, contact us to learn how you can join our T1D Moonshot.


How GO-Pen’s “Insulin Pen for All” Is Making High-Quality T1D Care Globally Accessible



Our StartUp Health NOW guest this week is Ole Kjerkegaard Nielsen, PhD, CEO & Co-founder of GO-Pen, a company in our Type 1 Diabetes Moonshot community.

As you’ll hear, Nielsen and his team based in Denmark have built a new kind of insulin pen, one that is affordable and accessible to all while also adhering to the absolute highest standards of quality. This more accessible insulin pen could change millions of people’s lives.

We’ll also get a glimpse into the uniquely challenging startup journey of developing a physical medical device. Nielsen and his team have been winning awards and grants on a regular basis, but the road is still steep. Whether it’s negotiating with a manufacturer across the globe or getting FDA approval, bringing a medical device to market as a startup with limited funds is a challenge that could intimidate even the most market-tested CEOs. Nielsen pulls back the curtain and lets us see that challenge from the inside and shows us where GO-Pen is going next.

Enjoy!


FundersBecome a Health Moonshot Champion
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Looking to break down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.
Passionate about Type 1 diabetes? If you’re an entrepreneur or investor, contact us to learn how you can join our T1D Moonshot.


Former Dexcom Exec Claudia Graham Joins StartUp Health’s New T1D Moonshot Impact Board



“The more you know, the better you’ll do living with diabetes,” says Claudia Graham. “There’s nothing more important in diabetes than empowering patients.”

If you follow StartUp Health at all, you have seen headlines about our new Type 1 Diabetes Moonshot. To recap, we’ve launched an initiative designed to speed up innovation around Type 1 diabetes by bringing together a cross-disciplinary team of investors, entrepreneurs, philanthropists, researchers, and other industry experts. At the heart of the effort is an Impact Board – basically our T1D dream team – which brings together the top minds in the field for collaborative working sessions. We wanted to take some time on this podcast to introduce you to some of the inspiring folks on this Impact Board and invite you to get involved in the effort.

On this episode you’ll meet Claudia Graham, former executive at Dexcom, the company that revolutionized the continuous glucose monitor. She served as VP of Marketing and SVP of Global Access. Now she’s putting her decades of experience at Dexcom – and as someone living with Type 1 diabetes – to work as an advisor and investor. We caught up with Claudia over zoom at her home in Idaho to learn about the opportunities and challenges she sees in the Type 1 Diabetes Moonshot, how StartUp Health helps get away from institutional thinking to break down barriers and empower patients, and how she thinks about leaving a legacy for the next generation.


Entrepreneurs, are you working on a T1D solution? We want to hear from you.
Investors, want to back an impact-driven fund laser focused on T1D? Contact us.

Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

 


David Weingard Breaks Down the Mission and Vision of StartUp Health’s New T1D Moonshot



This week’s episode is a conversation with a very special guest, David Weingard. For years StartUp Health backed his work as a founder as he built up a startup called Cecelia Health that provides a combination of high-tech and high-touch care for people with diabetes. Now David is leading a new initiative here at StartUp Health, the Type 1 Diabetes Moonshot. As the Chief Impact Officer, David has brought together an all-star team of T1D advocates to further this moonshot by onboarding investors, entrepreneurs, and researchers who are building the future of health. Hear how the Type 1 Diabetes Moonshot Impact Board is breaking down silos and speeding up innovation — and how you can join the effort.


 

Entrepreneurs, are you working on a T1D solution? We want to hear from you.
Investors, want to back an impact-driven fund laser focused on T1D? Contact us.

Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.